Atosiban Products | Cleanchem - Atosiban is an oxytocin receptor antagonist used as a tocolytic to delay preterm labor. It inhibits the action of oxytocin on the uterus, reducing uterine contractions. It is administered intravenously and has fewer cardiovascular side effects compared to beta-agonist tocolytics. It is approved for use in several countries in Europe and Asia.

Atosiban Acetate

Cat. No: CL-ATSN-01

CAS No: 914453-95-5

Mol. F: C43H67N11O12S2 : C2H4O2

Mol. Wt: 994.2 : 60.1

Inv. Status: Custom Synthesis

Atosiban Impurity B

Cat. No: CL-ATSN-02

CAS No: 960411-86-3

Mol. F: C43H69N11O12S2

Mol. Wt: 996.2

Inv. Status: Custom Synthesis

Atosiban Impurity D

Cat. No: CL-ATSN-03

CAS No: NA

Mol. F: C43H68N10O13S2

Mol. Wt: 997.2

Inv. Status: Custom Synthesis

Atosiban Impurity F

Cat. No: CL-ATSN-04

CAS No: NA

Mol. F: C43H68N10O13S2

Mol. Wt: 997.2

Inv. Status: Custom Synthesis

Atosiban Impurity G

Cat. No: CL-ATSN-05

CAS No: NA

Mol. F: C41H61N9O11S2

Mol. Wt: 920.1

Inv. Status: Custom Synthesis

Atosiban Impurity 1

Cat. No: CL-ATSN-06

CAS No: 2381861-04-5

Mol. F: C27H34N4O6

Mol. Wt: 510.6

Inv. Status: Custom Synthesis

Atosiban Impurity 2

Cat. No: CL-ATSN-07

CAS No: 90779-69-4

Mol. F: C43H67N11O12S2

Mol. Wt: 994.2

Inv. Status: Custom Synthesis

(Orn(Atosiban(Free acid))8)-Atosiban TFA salt

Cat. No: CL-ATSN-08

CAS No: NA

Mol. F: C83H125N21O23S4 : C2HF3O2

Mol. Wt: 1913.3 : 114.0

Inv. Status: Custom Synthesis

(Orn(Ac)8)-Atosiban

Cat. No: CL-ATSN-09

CAS No: NA

Mol. F: C45H69N11O13S2

Mol. Wt: 1036.2

Inv. Status: Custom Synthesis

Atosiban Nono Cyclic Impurity

Cat. No: CL-ATSN-10

CAS No: NA

Mol. F: C46H74N12O13S2

Mol. Wt: 1067.3

Inv. Status: Custom Synthesis